The Big Story

COVID-19: British drugmaker AstraZeneca aiming to make 2 billion doses of vaccine starting this September

by Muhereza Kyamutetera
AstraZeneca’s headquarters in Luton, Britain. The British drugmaker is championing efforts to make as much as 2 billion vaccine shots annually starting this September, raising hopes that the world could quickly get back on its feet.
Getting your Trinity Audio player ready...
British Pharmaceutical Company AstraZeneca has said they are gunning to start manufacturing and distributing as many as 2 billion doses of a coronavirus vaccine, including 400 million for the U.S. and U.K. and up to 1 billion for low and middle income countries by as early as September this year. If all goes well, the inoculation doses for the US and UK may go into distribution this September o

Thank You For Reading CEO East Africa Magazine.

Please SUBSCRIBE for UNLIMITED ACCESS to our game-changing stories or LOG IN for existing members.

Tagged:
About the Author

Muhereza Kyamutetera is the Executive Editor of CEO East Africa Magazine. I am a travel enthusiast and the Experiences & Destinations Marketing Manager at EDXTravel. Extremely Ugandaholic. Ask me about #1000Reasons2ExploreUganda and how to Take Your Place In The African Sun.